KAYLA MCGARVEY: Open Payments
NPI 1265204101 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 46 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $753 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $231 |
| Novo Nordisk Inc | 6 | $154 |
| Lilly USA, LLC | 6 | $113 |
| PFIZER INC. | 4 | $93 |
| Exact Sciences Corporation | 3 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Merck Sharp & Dohme LLC | 2 | $58 |
| Astellas Pharma US Inc | 2 | $56 |
| Xeris Pharmaceuticals, Inc. | 3 | $49 |
| Recor Medical Inc | 1 | $24 |
Products named: VRAYLAR, MOUNJARO, Wegovy, JARDIANCE, CAPVAXIVE, Veozah, PREVNAR 20, The Cologuard Plus Collection Kit.
Industry payments across MD — which companies pay providers there.
